Fondren Management’s Omega Protein OME Stock Holding History

Fondren Management’s Portfolio OME Stock Details OME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,389,000	Closed	-$23.1M	–	72
2017 Q3	$23.1M	Buy	1,389,000 +1,098,300	+378%	+$17.9M	18.59%	1
2017 Q2	$5.2M	Buy	290,700 +69,140	+31%	+$1.29M	5.67%	7
2017 Q1	$4.44M	Buy	+221,560	New	+$5.16M	4.76%	7

Fondren Management's OME Position: Q4 2017 in Review

Fondren Management sold out of Omega Protein (OME) in Q4 2017, closing a stake of 1,389,000 shares — an estimated $23.1M sold.

Fondren Management first reported a position in OME in Q1 2017 and held it in 3 quarters. The position peaked at $23.1M in Q3 2017. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.

Fondren Management reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
Fondren Management sold 1,389,000 Omega Protein shares in Q4 2017, an estimated $23.1M.
Fondren Management first reported a position in Omega Protein in Q1 2017 and held it in 3 quarters.
Fondren Management's Omega Protein position peaked at $23.1M in Q3 2017.
0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.

Based on Fondren Management's 13F filing for Q4 2017, filed 14 Feb 2018.